Vice president of Cathay Investment Fund
Life Sciences Ph.D. / MBA, BayHelix Member
Zhong Jing focuses on biotechnology innovative drugs, IVD diagnosis, medical devices, and other fields. He has been engaged in molecular diagnostics and RNA interference research for many years. He has worked in Starting Gate Partners Fund (US), BGI, Guoke Jiahe Fund, and has served as assistant to the chairman of Dikang Pharmaceutical. He has led Weiyuan Medical, Maijing Gene, and Jingliang Gene, Wei Gene, and other investments, and participated in the financing of MGI and MGI Genenoin.
He holds a Ph.D. in Cell Molecular Biology from the University of California and an MBA from the University of North Carolina. He is also a Tsinghua Economic Management Entrepreneur Accelerator Mentor. He is an award-winning member of the American Society of Virology/Genetic Society.